Knights of Columbus Asset Advisors LLC Has $14.26 Million Stock Holdings in Cencora, Inc. $COR

Knights of Columbus Asset Advisors LLC decreased its stake in Cencora, Inc. (NYSE:COR) by 7.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 42,225 shares of the company’s stock after selling 3,638 shares during the period. Cencora accounts for about 0.8% of Knights of Columbus Asset Advisors LLC’s holdings, making the stock its 22nd biggest holding. Knights of Columbus Asset Advisors LLC’s holdings in Cencora were worth $14,261,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently made changes to their positions in COR. United Bank increased its stake in shares of Cencora by 4.5% in the second quarter. United Bank now owns 7,032 shares of the company’s stock valued at $2,109,000 after buying an additional 305 shares during the period. Nebula Research & Development LLC acquired a new stake in Cencora during the second quarter worth approximately $595,000. Treasurer of the State of North Carolina grew its stake in Cencora by 7.9% during the second quarter. Treasurer of the State of North Carolina now owns 85,534 shares of the company’s stock worth $25,647,000 after purchasing an additional 6,244 shares during the period. Diversify Advisory Services LLC grew its stake in Cencora by 94.1% during the second quarter. Diversify Advisory Services LLC now owns 2,585 shares of the company’s stock worth $747,000 after purchasing an additional 1,253 shares during the period. Finally, DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main grew its stake in Cencora by 26.0% during the second quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main now owns 73,452 shares of the company’s stock worth $22,025,000 after purchasing an additional 15,154 shares during the period. Institutional investors and hedge funds own 97.52% of the company’s stock.

Cencora Stock Down 1.1%

COR stock opened at $271.84 on Wednesday. Cencora, Inc. has a twelve month low of $244.82 and a twelve month high of $377.54. The company has a quick ratio of 0.59, a current ratio of 0.95 and a debt-to-equity ratio of 3.40. The stock’s 50 day moving average is $302.59 and its 200-day moving average is $335.67. The firm has a market capitalization of $52.89 billion, a PE ratio of 20.85, a P/E/G ratio of 1.27 and a beta of 0.64.

Cencora (NYSE:COR) last posted its earnings results on Wednesday, May 6th. The company reported $4.75 earnings per share for the quarter, missing analysts’ consensus estimates of $4.82 by ($0.07). Cencora had a net margin of 0.78% and a return on equity of 135.20%. The company had revenue of $78.36 billion during the quarter, compared to the consensus estimate of $81.09 billion. During the same quarter in the prior year, the business earned $4.42 EPS. The firm’s revenue for the quarter was up 3.9% compared to the same quarter last year. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. Sell-side analysts expect that Cencora, Inc. will post 17.79 EPS for the current fiscal year.

Cencora declared that its board has authorized a share buyback plan on Thursday, May 21st that authorizes the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization authorizes the company to reacquire up to 3.9% of its stock through open market purchases. Stock repurchase plans are usually a sign that the company’s leadership believes its shares are undervalued.

Cencora Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, June 1st. Stockholders of record on Friday, May 15th will be issued a $0.60 dividend. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date is Friday, May 15th. Cencora’s dividend payout ratio (DPR) is currently 18.40%.

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on the company. Weiss Ratings cut Cencora from a “buy (b)” rating to a “buy (b-)” rating in a research note on Friday. JPMorgan Chase & Co. raised their target price on Cencora from $417.00 to $419.00 and gave the stock an “overweight” rating in a research note on Tuesday, February 10th. Wells Fargo & Company decreased their target price on Cencora from $429.00 to $331.00 and set an “overweight” rating for the company in a research note on Monday, May 11th. UBS Group raised their price objective on Cencora from $410.00 to $412.00 and gave the company a “buy” rating in a research note on Thursday, May 7th. Finally, Barclays raised their price objective on Cencora from $400.00 to $425.00 and gave the company an “overweight” rating in a research note on Friday, February 13th. Twelve research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $380.25.

Cencora Company Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.